Skip to content

Clinical trials

Completed Phase 2 Autistic Disorder trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Autistic Disorder Phase: Phase 2 Status: Completed Clear all

78 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20024
20031
20042
20053
20064
20072
20086
20095
20102
20118
20128
20134
20144
20151
20168
20175
20182
20193
20202
20222
20242

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed78

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Stanford University5
University of North Carolina, Chapel Hill5
Forest Laboratories4
Holland Bloorview Kids Rehabilitation Hospital3
Neuren Pharmaceuticals Limited3
Arizona State University2
Drexel University College of Medicine2
Evdokia Anagnostou2
Joanne Kurtzberg, MD2
Seaside Therapeutics, Inc.2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Autistic Disorder78
Autism Spectrum Disorder30
Asperger Syndrome10
Child Development Disorders, Pervasive7
Fragile X Syndrome6
Anxiety Disorders4
Epilepsy3
Ataxia2
Brain Diseases2
Central Nervous System Diseases2

Trials

Showing 1 to 25 of 78. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.